LifeStance Health Group Target of Unusually Large Options Trading (NASDAQ:LFST)

LifeStance Health Group, Inc. (NASDAQ:LFST) was the recipient of unusually large options trading activity on Tuesday. Investors purchased 4,000 put options on the company. This represents an increase of approximately 292% compared to the average volume of 1,020 put options.

Insider Buying and Selling

In other news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now owns 339,810 shares of the company’s stock, valued at $2,344,689. The trade was a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 6.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On LifeStance Health Group

Several large investors have recently made changes to their positions in the business. Blue Trust Inc. increased its holdings in LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after purchasing an additional 2,122 shares in the last quarter. Townsquare Capital LLC purchased a new stake in shares of LifeStance Health Group during the 3rd quarter valued at about $73,000. R Squared Ltd acquired a new position in LifeStance Health Group during the 4th quarter worth approximately $80,000. Ameriprise Financial Inc. purchased a new position in LifeStance Health Group in the 4th quarter worth approximately $87,000. Finally, Cibc World Markets Corp acquired a new stake in LifeStance Health Group in the fourth quarter valued at approximately $96,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a report on Monday, December 16th. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, LifeStance Health Group has an average rating of “Hold” and an average price target of $8.63.

LifeStance Health Group Trading Down 0.3 %

LFST traded down $0.02 on Tuesday, reaching $6.64. 737,397 shares of the company’s stock were exchanged, compared to its average volume of 1,588,189. The company has a market cap of $2.55 billion, a price-to-earnings ratio of -25.53 and a beta of 1.27. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $8.61. The company’s 50 day moving average is $7.57 and its 200-day moving average is $7.35.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.